# FDA Inspection 873916 - Warren General Hospital - April 10, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/warren-general-hospital/dd51ef2a-00bd-48a7-8c7b-6bab09395e8d
Source feed: FDA_Inspections

> FDA Inspection 873916 for Warren General Hospital on April 10, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 873916
- Company Name: Warren General Hospital
- Inspection Date: 2014-04-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1031114 - 2017-10-19](https://www.globalkeysolutions.net/records/fda_inspections/warren-general-hospital/0124e23f-32a9-488c-8ce7-a278c060852f)
- [FDA Inspection 979169 - 2016-07-07](https://www.globalkeysolutions.net/records/fda_inspections/warren-general-hospital/75fe0550-d043-42e2-b8cd-5d8931f0d5d8)
- [FDA Inspection 772474 - 2012-03-13](https://www.globalkeysolutions.net/records/fda_inspections/warren-general-hospital/17075cec-039d-4f56-9aa2-76723bcd9d2b)
- [FDA Inspection 659428 - 2010-04-28](https://www.globalkeysolutions.net/records/fda_inspections/warren-general-hospital/9bbc2c15-e444-4ce8-a0a2-a0d08399a75f)

Company: https://www.globalkeysolutions.net/companies/warren-general-hospital/9e7db372-7734-4251-8928-74f7927bbadc

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
